The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide–peptidoglycan model of sepsis

Sprung, 2008, Hydrocortisone therapy for patients with septic shock, N. Engl. J. Med., 358, 111, 10.1056/NEJMoa071366 2007, The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand, Crit. Care Resusc., 9, 8 Crouser, 2004, Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome, Mitochondrion, 4, 729, 10.1016/j.mito.2004.07.023 Levy, 2007, Mitochondrial dysfunction, bioenergetic impairment and metabolic down-regulation in sepsis, Shock, 28, 24, 10.1097/01.shk.0000235089.30550.2d Abraham, 2007, Mechanisms of sepsis induced organ dysfunction, Crit. Care Med., 35, 2408, 10.1097/01.CCM.0000282072.56245.91 Goode, 1995, Decreased antioxidant status and increased lipid peroxidation in patients with sepsis and secondary organ dysfunction, Crit. Care Med., 23, 646, 10.1097/00003246-199504000-00011 Galley, 1996, Xanthine oxidase activity and free radical generation in patients with sepsis syndrome, Crit. Care Med., 24, 1649, 10.1097/00003246-199610000-00008 Galley, 1996, Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome, Intensive Care Med., 22, 226, 10.1007/BF01712241 Galley, 1995, Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading, Free Radic. Biol. Med., 20, 139, 10.1016/0891-5849(95)02022-5 Galley, 1997, The effects of intravenous antioxidants in patients with septic shock, Free Radic. Biol. Med., 23, 768, 10.1016/S0891-5849(97)00059-2 Gellerich, 1999, Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain, Shock, 11, 336, 10.1097/00024382-199905000-00006 Brealey, 2004, Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure, Am. J. Physiol.: Regul. Integr. Comp. Physiol., 286, R491, 10.1152/ajpregu.00432.2003 Vanhorebeek, 2005, Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients, Lancet, 365, 53, 10.1016/S0140-6736(04)17665-4 Yassen, 1999, Mitochondrial redox state in the critically ill, Br. J. Anaesth., 83, 325, 10.1093/bja/83.2.325 Zapelini, 2008, Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model, Mitochondrion, 10.1016/j.mito.2008.03.002 Mishra, 2007, Oxidative stress and role of antioxidant supplementation in critical illness, Clin. Lab., 53, 199 Crimi, 2006, The role of oxidative stress in adult critical care, Free Radic. Biol. Med.;, 40, 398, 10.1016/j.freeradbiomed.2005.10.054 Murphy, 2007, Targeting antioxidants to mitochondria by conjugation to lipophilic cations, Annu. Rev. Pharmacol. Toxicol., 47, 629, 10.1146/annurev.pharmtox.47.120505.105110 Kelso, 2001, Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties, J. Biol. Chem., 276, 4588, 10.1074/jbc.M009093200 Ross, 2008, Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells, Biochem. J., 411, 633, 10.1042/BJ20080063 Smith, 2003, Delivery of bioactive molecules to mitochondria in vivo, Proc. Natl. Acad. Sci. USA, 100, 5407, 10.1073/pnas.0931245100 Adlam, 2005, Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury, FASEB J., 19, 1088, 10.1096/fj.05-3718com Neuzil, 2007, Mitochondria transmit apoptosis signalling in cardiomyocyte-like cells and isolated hearts exposed to experimental ischemia-reperfusion injury, Redox Rep., 12, 148, 10.1179/135100007X200227 Esplugues, 2006, Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants, Circ. Res., 99, 1067, 10.1161/01.RES.0000250430.62775.99 Wray, 2001, A cell wall component from pathogenic and nonpathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of TNFα, nitric oxide production, shock, and multiple organ dysfunction in the rat, Shock, 15, 135, 10.1097/00024382-200115020-00010 Yang, 1996, An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells, Anal. Biochem., 241, 103, 10.1006/abio.1996.0383 Qin, 2005, Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress, FASEB J., 19, 550, 10.1096/fj.04-2857com Reers, 1991, J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential, Biochemistry, 30, 4480, 10.1021/bi00232a015 Salvioli, 1997, JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis, FEBS Lett., 41, 77, 10.1016/S0014-5793(97)00669-8 Briese, 1998, Normal body temperature of rats: the setpoint controversy, Neurosci. Biobehav. Rev., 22, 427, 10.1016/S0149-7634(97)00051-1 Galley, 2001, Differential nitric oxide synthase activity, cofactor availability and cGMP accumulation in the central nervous system during anaesthesia, Br. J. Anaesth., 86, 388, 10.1093/bja/86.3.388 Peake, 2006, Measurement of serum creatinine—current status and future goals, Clin. Biochem. Rev., 27, 173 Ozer, 2008, The current state of serum biomarkers of hepatotoxicity, Toxicology, 245, 194, 10.1016/j.tox.2007.11.021 Grandel, 2003, Endothelial responses to bacterial toxins in sepsis, Crit. Rev. Immunol., 23, 267, 10.1615/CritRevImmunol.v23.i4.20 Dinarello, 2005, Interleukin-1β, Crit. Care Med., 33, S460, 10.1097/01.CCM.0000185500.11080.91 Latifi, 2004, Persistent elevation of serum interleukin-6 in intra-abdominal sepsis identifies those with prolonged length of stay, J. Pediatr. Surg., 39, 1548, 10.1016/j.jpedsurg.2004.06.015 Marty, 1994, Circulating interleukin-8 concentrations in patients with multiorgan failure of septic or nonseptic origin, Crit. Care Med., 22, 673, 10.1097/00003246-199404000-00025 Scumpia, 2005, Biology of interleukin-10 and its regulatory roles in sepsis syndromes, Crit. Care Med., 33, S468, 10.1097/01.CCM.0000186268.53799.67 Murch, 2006, Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock, Br. J. Pharmacol., 148, 769, 10.1038/sj.bjp.0706788 Dugo, 2006, Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition, Crit. Care Med., 34, 1489, 10.1097/01.CCM.0000215457.83953.E3 Reinhart, 2001, Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: the RAMSES study, Crit. Care Med., 29, 765, 10.1097/00003246-200104000-00015 Alonso de Vega, 2002, Oxidative stress in critically ill patients with systemic inflammatory response syndrome, Crit. Care Med., 30, 1782, 10.1097/00003246-200208000-00018 Singer, 2007, Mitochondrial function in sepsis: acute phase versus multiple organ failure, Crit. Care Med., 35, S441, 10.1097/01.CCM.0000278049.48333.78 Jauslin, 2003, Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants, FASEB J., 17, 1972, 10.1096/fj.03-0240fje